art
Showing 1 - 12 of 12
HIV-1-infection Trial in Kisumu, Thika (Integrated PrEP as a bridge to ART HIV-1 prevention strategy, PrEP, ART)
Completed
- HIV-1-infection
- Integrated PrEP as a bridge to ART HIV-1 prevention strategy
- +2 more
-
Kisumu, Kenya
- +1 more
Oct 17, 2021
Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)
Recruiting
- Human Immunodeficiency Virus
- brentuximab vedotin
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 29, 2022
HIV-1-infection Trial in Mbeya (ART, 10E8.4/iMab, VRC07-523LS)
Not yet recruiting
- HIV-1-infection
- ART
- +2 more
-
Mbeya, TanzaniaNational Institute for Medical Research-Mbeya Medical Resarch Ce
Jun 6, 2023
Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)
Not yet recruiting
- Acute HIV Infection
- VRC07-523LS
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 30, 2023
Covid19, Hiv, ART Trial in Ilorin, Lagos, Mthatha (COVID-19, HIV, ART)
Recruiting
- Covid19
- +2 more
- COVID-19
- +2 more
-
Ilorin, Kwara State, Nigeria
- +2 more
Aug 31, 2021
Dental Caries, Child Discomfort Trial in Alexandria (SDF, ART)
Completed
- Dental Caries
- Child Discomfort
- SDF
- ART
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Nov 27, 2020
HIV-1 Infection Trial in United States (Vesatolimod, Placebo, ART)
Early Childhood Caries Trial in Alexandria (SDF, ART)
Completed
- Early Childhood Caries
- SDF
- ART
-
Alexandria, EgyptFaculty of Dentistry, Alexandria University
Aug 13, 2020
HIV Infection Trial in Kenya, Uganda (FTC-TDF PrEP, ART)
Completed
- HIV Infection
- FTC-TDF PrEP
- ART
-
Kisumu, Kenya
- +3 more
Dec 7, 2017